Hence, the authors believed that the stem cell-associated genes (NANOG, POU5F1, and SOX2) may serve as promising markers and that BBR can be considered a potent anticancer agent for the treatment of pancreatic cancers [73]. The gene discussed is POU5F1; the disease is familial pancreatic carcinoma.